Optimising surveillance for relapse of Wilms' tumour
- PMID: 29960847
- PMCID: PMC6626618
- DOI: 10.1016/S1470-2045(18)30440-6
Optimising surveillance for relapse of Wilms' tumour
Conflict of interest statement
I declare no competing interests.
Comment on
-
Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.Lancet Oncol. 2018 Aug;19(8):1072-1081. doi: 10.1016/S1470-2045(18)30293-6. Epub 2018 Jun 27. Lancet Oncol. 2018. PMID: 29960848
References
-
- Spreafico F, Pritchard Jones K, Malogolowkin MH, et al. Treatment of relapsed Wilms tumors: lessons learned. Expert Rev Anticancer Ther 2009; 9: 1807–15. - PubMed
-
- Ha TC, Spreafico F, Graf N, et al. An international strategy to determine the role of high dose therapy in recurrent Wilms’ tumour. Eur J Cancer 2013; 49: 194–210. - PubMed
-
- Wong KF, Reulen RC, Winter DL, et al. Risk of Adverse health and social outcomes up to 50 years after Wilms tumor: the British childhood cancer survivor study. J Clin Oncol 2016; 34: 1772–79. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
